Previous 10 | Next 10 |
IDEXX is benefiting from several tailwinds in the health and diagnostics companion animal market, allowing it to grow at double-digit rates. IDEXX has a solid balance sheet, attractive financials, and growth opportunities for the next decade, especially international expansion. Un...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips When cuddling our furry, feathered and scaly companions, it can be hard to fathom that there’s a $100 billion industry across a variety of sectors supporting their spoiled rotten lifestyles. That’s why ProSh...
On Nov. 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q3 2021. I curated a list of some of the best-performing hedge funds and looked into their holdings at the end of September 2021. Several common themes appea...
My new portfolio has already seen most companies release earnings, and results look promising. Therefore, I will cover the first thirteen companies in this article, and then the last twelve after all reports have been filed. I will be quite brief with my summaries, but I will cove...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
The pet product and services industry has grown significantly over the last two decades as the humanization of pets has driven increased consumer spending. Shifts in consumer attitudes toward pets, which accelerated during the COVID-19 pandemic, have resulted in a greater demand for, ...
Image source: The Motley Fool. IDEXX Laboratories, inc (NASDAQ: IDXX) Q3 2021 Earnings Call Nov 2, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: IDEXX Laboratories, inc (IDXX) Q3 2021 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q3 Earnings Conference Call November 2, 2021, 8:30 AM ET Company Participants Jay Mazelsky – President and Chief Executive Officer John Ravis – Senior Director Investor Relations Brian Mc Keon – Chief Financial Officer Conference Call Parti...
IDEXX Laboratories (NASDAQ:IDXX): Q3 Non-GAAP EPS of $1.96 beats by $0.05; GAAP EPS of $2.03 beats by $0.15. Revenue of $810.42M (+12.3% Y/Y) beats by $12.81M. Press Release Updates 2021 guidance to higher end of previous guidance ranges, reflecting revenue growth outlook of 17.5% - 18% as re...
IDEXX Laboratories (NASDAQ:IDXX) is scheduled to announce Q3 earnings results on Tuesday, November 2nd, before market open. The consensus EPS Estimate is $1.91 (+9.1% Y/Y) and the consensus Revenue Estimate is $797.61M (+10.5% Y/Y). IDEXX Laboratories reported second-quarter results that beat...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories Inc. Website:
IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals PR Newswire WESTBROOK, Maine , July 30, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published i...
2024-07-19 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 23:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...